Luo Fei - Net Worth and Insider Trading

Luo Fei Net Worth

The estimated net worth of Luo Fei is at least $0 dollars as of 2025-04-21. Luo Fei is the Supervisors of Pharma Block Sciences (Nanjing) Inc and owns about 0 shares of Pharma Block Sciences (Nanjing) Inc (SZSE:300725) stock worth over $0. Details can be seen in Luo Fei's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Luo Fei has not made any transactions after 2018-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Luo Fei

Luo Fei Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luo Fei owns 1 companies in total, including Pharma Block Sciences (Nanjing) Inc (SZSE:300725) .

Click here to see the complete history of Luo Fei’s form 4 insider trades.

Insider Ownership Summary of Luo Fei

Ticker	Comapny	Transaction Date	Type of Owner
SZSE:300725	Pharma Block Sciences (Nanjing) Inc	2018-09-03	Supervisors

Luo Fei Latest Holdings Summary

Luo Fei currently owns a total of 1 stock. Luo Fei owns 0 shares of Pharma Block Sciences (Nanjing) Inc (SZSE:300725) as of September 3, 2018, with a value of $0.

Latest Holdings of Luo Fei

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:300725	Pharma Block Sciences (Nanjing) Inc	2018-09-03	0	30.58	0

Holding Weightings of Luo Fei

Luo Fei Form 4 Trading Tracker

According to the SEC Form 4 filings, Luo Fei has made a total of 0 transactions in Pharma Block Sciences (Nanjing) Inc (SZSE:300725) over the past 5 years. The most-recent trade in Pharma Block Sciences (Nanjing) Inc is the sale of 169 shares on September 3, 2018, which brought Luo Fei around $5,923.

Insider Trading History of Luo Fei

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Luo Fei Trading Performance

GuruFocus tracks the stock performance after each of Luo Fei's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luo Fei is 20.93%. GuruFocus also compares Luo Fei's trading performance to market benchmark return within the same time period. The performance of stocks bought by Luo Fei within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Luo Fei's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Luo Fei

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	8.94
Relative Return to S&P 500(%)	6.22

Luo Fei Ownership Network

Ownership Network List of Luo Fei

No Data

Ownership Network Relation of Luo Fei

Luo Fei Owned Company Details

What does Pharma Block Sciences (Nanjing) Inc do?

Who are the key executives at Pharma Block Sciences (Nanjing) Inc?

Luo Fei is the Supervisors of Pharma Block Sciences (Nanjing) Inc. Other key executives at Pharma Block Sciences (Nanjing) Inc include Directors & executives yang min min , Directors & executives , and Executives Chen La Mei .

Pharma Block Sciences (Nanjing) Inc (SZSE:300725) Insider Trades Summary

Over the past 18 months, Luo Fei made no insider transaction in Pharma Block Sciences (Nanjing) Inc (SZSE:300725). Other recent insider transactions involving Pharma Block Sciences (Nanjing) Inc (SZSE:300725) include a net purchase of 96,300 shares made by yang min min ,

In summary, during the past 3 months, insiders sold 0 shares of Pharma Block Sciences (Nanjing) Inc (SZSE:300725) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pharma Block Sciences (Nanjing) Inc (SZSE:300725) were sold and 96,300 shares were bought by its insiders, resulting in a net purchase of 96,300 shares.

Pharma Block Sciences (Nanjing) Inc (SZSE:300725)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pharma Block Sciences (Nanjing) Inc Insider Transactions

No Available Data

Luo Fei Mailing Address

Above is the net worth, insider trading, and ownership report for Luo Fei. Currently GuruFocus does not have mailing address information for Luo Fei.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.